STOCK TITAN

Opus Genetics: Perceptive reports 9.99% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Opus Genetics, Inc. (IRD) reports that Perceptive Advisors LLC, its managing member Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. each report beneficial ownership of 10,086,525 shares, or 9.99%, with shared voting and dispositive power. The three reports describe the same shared position. Neither Perceptive Advisors nor Edelman directly holds common shares; the Master Fund is the direct holder.

The Master Fund directly holds 5,774,644 common shares and pre-funded warrants to purchase 17,775,479 shares at $0.0001 per share. The 9.99% beneficial-ownership limit permits exercise of warrants for up to 4,311,881 shares. The reported percentages use 96,654,336 shares outstanding as of November 6, 2026, and assume exercise for 4,311,881 shares.

Beneficial ownership 10,086,525 shares Reported by each of the three reporting persons, with shared voting and dispositive power
Percentage of class 9.99% Reported by each of the three reporting persons
Direct common shares 5,774,644 shares Held directly by Perceptive Life Sciences Master Fund, Ltd.
Pre-funded warrants 17,775,479 shares Shares the warrants held by the Master Fund may be used to purchase
Warrant exercise limit 4,311,881 shares Maximum shares permitted to be acquired through warrant exercise under the beneficial-ownership limit
Warrant exercise price $0.0001 per share Exercise price of the pre-funded warrants
Shares outstanding 96,654,336 shares As of November 6, 2026; basis cited for reported ownership percentages
Pre-Funded Warrants financial
"pre-funded warrants (the “Pre-Funded Warrants”) to purchase"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Limitation regulatory
"subject to the Beneficial Ownership Limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Section 13(d) regulatory
"as determined in accordance with Section 13(d)"
A Section 13(d) filing is a public disclosure required under U.S. securities law when a person or group acquires more than 5% of a company’s registered equity and may influence control. The filer must report who owns the shares, how they were acquired, and any plans or intentions for the company, so the market and other shareholders can see if a large buyer is attempting a takeover or other strategic move. Think of it like a formal announcement that someone has crossed a threshold and is showing their hand.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Opus Genetics (IRD) shares does Perceptive report beneficially owning?

Each of the three reporting persons—Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd.—reported beneficial ownership of 10,086,525 shares, equal to 9.99% of the class. They each reported shared voting and dispositive power over the same position.

How many IRD shares does Perceptive Life Sciences Master Fund hold directly?

The Master Fund directly holds 5,774,644 shares of common stock. It also holds pre-funded warrants to purchase 17,775,479 shares at an exercise price of $0.0001 per share.

What does the ownership limit mean for IRD's pre-funded warrants?

The warrants may not be exercised if doing so would cause the reporting persons to beneficially own more than 9.99% of shares then issued and outstanding. The limit permits exercise of warrants for up to 4,311,881 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





67577R102

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:11/16/2026
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/16/2026

Keep reading